VERTEX PHARMACEUTICALS INC / MA Construction in Progress, Gross
VERTEX PHARMACEUTICALS INC / MA (VRTX) had Construction in Progress, Gross of $518.30 million as of 2014-09-30, per its 10-Q filed 2014-11-06.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:ConstructionInProgressGross · last filed 2014-11-06
- 2014-09-30: Construction in Progress, Gross $518.30M.
- 2014-06-30: Construction in Progress, Gross $522.20M.
- 2014-03-31: Construction in Progress, Gross $525.50M.
- 2013-12-31: Construction in Progress, Gross $503.40M.
| Period end | Construction in Progress, Gross |
|---|---|
| 2014-09-30 | $518.30M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $522.20M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $525.50M 10-Q · filed 2014-05-05 |
| 2013-12-31 | $503.40M 10-Q · filed 2014-11-06 |
| 2013-09-30 | $467.60M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $421.30M 10-Q · filed 2013-08-02 |
| 2013-03-31 | $356.90M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $290.70M 10-Q · filed 2013-11-07 |
| 2012-09-30 | $223.10M 10-Q · filed 2012-11-06 |
| 2011-12-31 | $55.07M 10-Q · filed 2012-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |